Minireviews
Copyright ©2014 Baishideng Publishing Group Inc.
World J Clin Cases. Dec 16, 2014; 2(12): 828-834
Published online Dec 16, 2014. doi: 10.12998/wjcc.v2.i12.828
Table 1 Sleep characteristics in interstitial lung disease
Sleep characteristicAbnormalityPatient groupRef.
Respiratory rateDecreasedILD[15]
UnchangedILD, IPF[11-14]
Stage 1/2 sleepIncreasedILD[14]
IPF[19,20]
REM sleepReducedILD[11,14,15,25]
Scleroderma[26]
IPF[2,19,20]
Slow wave sleepReducedIPF[13]
ILD[17,25]
Arousal indexIncreasedILD[12,14,15]
IPF[2,19,20]
Sleep efficiencyReducedILD[25]
IPF[13,19,20]
Table 2 Prevalence of obstructive sleep apnoea in interstitial lung disease populations n (%)
Ref.PopulationPrevalence of OSAM/FAge (mean)BMI(mean)Comment
Aydoğdu et al[18], 2006ILD24 (65)Abstract only
Mermigkis et al[17], 2007IPF11 (61)12/668.133.2Retrospective study; subjects with symptoms of SDB
Lancaster et al[19], 2009IPF44 (88)34/1665.732.2Prospective study of unselected patients; 16 subjects used oxygen during PSG
Mermigkis et al[20], 2010IPF20 (59)21/1365.027.3Prospective study of subjects with newly diagnosed IPF
Kolilekas et al[2], 2013IPF28 (90)24/768.028.7Increased AHI associated with decreased survival, after exclusion of those prescribed CPAP
Pihtili et al[25], 2013ILD34 (68)14/3653.925.9Prospective study; excluded obese subjects (BMI ≥ 30)
IPF14 (82)
Sarcoidosis10 (67)
Scleroderma10 (56)